PagerDuty, Inc.

More coverage

AC Immune: Buy Continued ACI-7104 Progress, PD, And Pipeline Expansions

Markets 1 h ago also on ACIU ACI

PagerDuty (PD) Hits A Milestone While Trimming Its Own Headcount

Markets 23 d ago

How to Play PD Stock as PagerDuty Lays Off 15% of Its Staff

Markets 27 d ago

BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

Markets 30 d ago also on SAN

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

Markets 30 d ago

BioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Transcript

Markets 42 d ago also on BIVI